↓ Skip to main content

Cochrane Database of Systematic Reviews

Cannabinoids for epilepsy

Overview of attention for article published in Cochrane database of systematic reviews, March 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Citations

dimensions_citation
138 Dimensions

Readers on

mendeley
482 Mendeley
Title
Cannabinoids for epilepsy
Published in
Cochrane database of systematic reviews, March 2014
DOI 10.1002/14651858.cd009270.pub3
Pubmed ID
Authors

David Gloss, Barbara Vickrey

Abstract

Marijuana appears to have anti-epileptic effects in animals. It is not currently known if it is effective in patients with epilepsy. Some states in the United States of America have explicitly approved its use for epilepsy.

Twitter Demographics

The data shown below were collected from the profiles of 33 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 482 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 5 1%
United Kingdom 2 <1%
Brazil 1 <1%
Puerto Rico 1 <1%
Peru 1 <1%
Unknown 472 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 102 21%
Researcher 67 14%
Student > Master 63 13%
Other 38 8%
Student > Ph. D. Student 36 7%
Other 95 20%
Unknown 81 17%
Readers by discipline Count As %
Medicine and Dentistry 146 30%
Pharmacology, Toxicology and Pharmaceutical Science 41 9%
Agricultural and Biological Sciences 37 8%
Psychology 32 7%
Neuroscience 32 7%
Other 91 19%
Unknown 103 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 153. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 June 2022.
All research outputs
#204,302
of 21,732,065 outputs
Outputs from Cochrane database of systematic reviews
#343
of 12,101 outputs
Outputs of similar age
#1,899
of 200,818 outputs
Outputs of similar age from Cochrane database of systematic reviews
#8
of 198 outputs
Altmetric has tracked 21,732,065 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,101 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.5. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 200,818 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 198 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.